Insights

Specialized Focus on Kidney Diseases Goldfinch Bio's exclusive dedication to developing precision medicines for kidney diseases positions it as a key partner for healthcare providers and pharmaceutical companies aiming to address unmet medical needs in nephrology. This focus offers potential sales opportunities for collaborations, licensing, or distribution of their advanced therapies.

Innovative Precision Medicine Pipeline With a robust pipeline targeting heterogeneous kidney conditions like FSGS and diabetic nephropathy, Goldfinch Bio presents opportunities to engage with specialists and institutions seeking cutting-edge treatments or clinical trial collaborations, expanding market reach and adoption.

Strategic Partnerships and Licensing Recent collaboration with Karuna Therapeutics indicates open channels for licensing deals on novel compound candidates. This suggests potential avenues for industry partners to co-develop or acquire rights to Goldfinch’s pipeline, increasing sales and expansion prospects.

Early-Stage Revenue Potential Although current revenue is minimal, the company’s significant funding and active clinical development hint at upcoming commercial launches. Engaging early with their sales pipeline could position partners to capitalize on the rollout of innovative kidney disease treatments.

Emerging Market Presence Goldfinch’s focus on molecular heterogeneity and personalized medicine aligns with current market trends toward targeted therapies, making it a promising candidate for partnerships with biotech or pharma companies looking to strengthen their nephrology portfolios.

Goldfinch Bio Tech Stack

Goldfinch Bio uses 8 technology products and services including GATK, Google Analytics Enhanced eCommerce, Google Fonts API, and more. Explore Goldfinch Bio's tech stack below.

  • GATK
    Analytics
  • Google Analytics Enhanced eCommerce
    Analytics
  • Google Fonts API
    Font Scripts
  • List.js
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • YouTube
    Video Players
  • Google Search Console
    Web Analytics

Media & News

Goldfinch Bio's Email Address Formats

Goldfinch Bio uses at least 1 format(s):
Goldfinch Bio Email FormatsExamplePercentage
FLast@goldfinchbio.comJDoe@goldfinchbio.com
100%

Frequently Asked Questions

Where is Goldfinch Bio's headquarters located?

Minus sign iconPlus sign icon
Goldfinch Bio's main headquarters is located at 215 First Street Suite 400 Cambridge, Massachusetts United States. The company has employees across 1 continents, including North America.

What is Goldfinch Bio's phone number?

Minus sign iconPlus sign icon
You can contact Goldfinch Bio's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Goldfinch Bio's official website and social media links?

Minus sign iconPlus sign icon
Goldfinch Bio's official website is goldfinchbio.com and has social profiles on LinkedInCrunchbase.

What is Goldfinch Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
Goldfinch Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Goldfinch Bio have currently?

Minus sign iconPlus sign icon
As of June 2026, Goldfinch Bio has approximately 5 employees across 1 continents, including North America. Key team members include Chief Information Officer: A. C.Vice President And Head, Regulatory Affairs And Quality Assurance: C. R.Owner: E. D.. Explore Goldfinch Bio's employee directory with LeadIQ.

What industry does Goldfinch Bio belong to?

Minus sign iconPlus sign icon
Goldfinch Bio operates in the Biotechnology Research industry.

What technology does Goldfinch Bio use?

Minus sign iconPlus sign icon
Goldfinch Bio's tech stack includes GATKGoogle Analytics Enhanced eCommerceGoogle Fonts APIList.jsModernizrMicrosoftYouTubeGoogle Search Console.

What is Goldfinch Bio's email format?

Minus sign iconPlus sign icon
Goldfinch Bio's email format typically follows the pattern of FLast@goldfinchbio.com. Find more Goldfinch Bio email formats with LeadIQ.

How much funding has Goldfinch Bio raised to date?

Minus sign iconPlus sign icon
As of June 2026, Goldfinch Bio has raised $100M in funding. The last funding round occurred on Jun 30, 2020 for $100M.

When was Goldfinch Bio founded?

Minus sign iconPlus sign icon
Goldfinch Bio was founded in 2016.

Goldfinch Bio

Biotechnology ResearchMassachusetts, United States2-10 Employees

With our sole focus on kidney diseases, we aspire to be the world’s leading precision medicine kidney company. There are few therapeutic options that target the underlying cause of disease. Our solution to address this growing need is applying precision medicine to pioneer the discovery, development and commercialization of kidney disease treatments. 

Historically, there has been a ‘one size fits all’ approach to treating kidney disease. This has been due to the lack of understanding of kidney disease at the molecular level.

Thanks to a growing understanding of kidney biology and genetics, including pioneering research by the founders of Goldfinch, the scientific community is starting to understand the heterogeneity inherent in kidney diseases. 

Our precision medicine product engine is the foundation of our approach. Our product engine allows us to discover and validate novel targets aimed at understanding the molecular and phenotypic heterogeneity in diverse patient populations to identify patient subsets most likely to respond to our treatment.

We have a robust pipeline of novel, precision medicine product candidates targeting kidney diseases with significant unmet medical need.

If embracing creativity and candor, thriving on challenges, and empowering your teammates to succeed excites and inspires you, join us as we champion hope and change the face of kidney disease.

Section iconCompany Overview

Headquarters
215 First Street Suite 400 Cambridge, Massachusetts United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
2-10

Section iconFunding & Financials

  • $100M

    Goldfinch Bio has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on Jun 30, 2020 in the amount of $100M.

  • $1M

    Goldfinch Bio's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $100M

    Goldfinch Bio has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on Jun 30, 2020 in the amount of $100M.

  • $1M

    Goldfinch Bio's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.